4.7 Review

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases

Journal

FRONTIERS IN ENDOCRINOLOGY
Volume 14, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2023.1239492

Keywords

cAMP; cGMP; phosphodiesterase; renin; aldosterone

Ask authors/readers for more resources

The renin-angiotensin-aldosterone system (RAAS) plays a crucial role in blood volume and blood pressure regulation, and its dysfunction is associated with cardiovascular and renal diseases. Cyclic nucleotides and phosphodiesterases are the main regulators of this system, controlling the expression and activity of renin and aldosterone. This review summarizes the known mechanisms by which cyclic nucleotides and phosphodiesterases regulate the expression of renin gene, secretion of renin granules, and production of aldosterone, as well as highlighting some unanswered questions for future research.
The renin-angiotensin-aldosterone system (RAAS) is one of the key players in the regulation of blood volume and blood pressure. Dysfunction of this system is connected with cardiovascular and renal diseases. Regulation of RAAS is under the control of multiple intracellular mechanisms. Cyclic nucleotides and phosphodiesterases are the major regulators of this system since they control expression and activity of renin and aldosterone. In this review, we summarize known mechanisms by which cyclic nucleotides and phosphodiesterases regulate renin gene expression, secretion of renin granules from juxtaglomerular cells and aldosterone production from zona glomerulosa cells of adrenal gland. We also discuss several open questions which deserve future attention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available